Clinical Trials in New York

Showing 7281-7300 of 22,668 trials

Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity

NCT04966741

This is a phase 3 open-label, clinical study to evaluate the efficacy, safety and tolerability of setmelanotide over 1 year of treatment, in pediatric participants aged 2 to \<6 years with obesity due to either biallelic variants of the pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1) or leptin receptor (LEPR) genes or Bardet-Biedl Syndrome (BBS).

Bardet-Biedl SyndromePOMC Deficiency ObesityPCSK1 Deficiency Obesity+1 more

Rhythm Pharmaceuticals, Inc.12 participantsStarted Mar 2022

Aurora, Colorado, United States • New York, New York, United States • Marshfield, Wisconsin, United States +3 more locations

COMPLETEDPhase 3< 1 mile

Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF

NCT04627025

The primary objective of the trial is the confirmation of the efficacy of apraglutide to evaluate the efficacy of weekly subcutaneous apraglutide in reducing parenteral support dependency.

Short Bowel Syndrome

VectivBio AG164 participantsStarted Jan 2021

Los Angeles, California, United States • Naples, Florida, United States • Chicago, Illinois, United States +65 more locations

Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity

Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF

Find Trials by Condition in New York

A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer

A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)

SCM Muscle as a Marker for Frailty in Patients Undergoing ENT Surgery

A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)

Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery

A Study of ZN-c3 in Patients With Ovarian Cancer

PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA)

Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction

Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder

First in Human Study of M1069 in Advanced Solid Tumors

Nurse Suicide: Physiologic Sleep Health Promotion Trial

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes

A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)

Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based Cohorts

Real-World Evaluation of Eko Algorithms in a Point of Care Setting

A Study of SPY002-072 in Healthy Volunteers

INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)

A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant